DK1176192T3 - Helicobacter felis-vaccine - Google Patents

Helicobacter felis-vaccine

Info

Publication number
DK1176192T3
DK1176192T3 DK01202666T DK01202666T DK1176192T3 DK 1176192 T3 DK1176192 T3 DK 1176192T3 DK 01202666 T DK01202666 T DK 01202666T DK 01202666 T DK01202666 T DK 01202666T DK 1176192 T3 DK1176192 T3 DK 1176192T3
Authority
DK
Denmark
Prior art keywords
subunit polypeptides
helicobacter felis
nucleic acid
acid sequences
vaccines
Prior art date
Application number
DK01202666T
Other languages
English (en)
Inventor
Johannes Gerardus Kusters
Giovanni Cattoli
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1176192T3 publication Critical patent/DK1176192T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01202666T 2000-07-17 2001-07-11 Helicobacter felis-vaccine DK1176192T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202565 2000-07-17

Publications (1)

Publication Number Publication Date
DK1176192T3 true DK1176192T3 (da) 2004-02-02

Family

ID=8171823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01202666T DK1176192T3 (da) 2000-07-17 2001-07-11 Helicobacter felis-vaccine

Country Status (10)

Country Link
US (1) US7514547B2 (da)
EP (1) EP1176192B1 (da)
JP (1) JP2002355054A (da)
AT (1) ATE251215T1 (da)
AU (1) AU782172B2 (da)
CA (1) CA2351110A1 (da)
DE (1) DE60100879T2 (da)
DK (1) DK1176192T3 (da)
ES (1) ES2208519T3 (da)
PT (1) PT1176192E (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029777B2 (en) 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
CN101048181A (zh) * 2004-08-13 2007-10-03 巴里·J·马沙尔 细菌递送系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
JPH08509873A (ja) * 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
JP3007037B2 (ja) * 1995-07-19 2000-02-07 秀実 高橋 ヘリコバクター・ピロリ菌ウレアーゼ蛋白由来の人工抗原及びその人工抗原によって誘発された抗体
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens

Also Published As

Publication number Publication date
JP2002355054A (ja) 2002-12-10
AU782172B2 (en) 2005-07-07
DE60100879T2 (de) 2004-05-19
EP1176192A3 (en) 2002-02-06
US7514547B2 (en) 2009-04-07
AU5432101A (en) 2002-01-24
ES2208519T3 (es) 2004-06-16
DE60100879D1 (de) 2003-11-06
EP1176192B1 (en) 2003-10-01
EP1176192A2 (en) 2002-01-30
PT1176192E (pt) 2004-01-30
US20040005325A1 (en) 2004-01-08
ATE251215T1 (de) 2003-10-15
CA2351110A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DK1219711T3 (da) Lawsonia Intracellularis vaccine
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
DK1176192T3 (da) Helicobacter felis-vaccine
ZA200602107B (en) Piroplasmid vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
TW200801034A (en) Novel sea lice vaccine
DK0995799T3 (da) Coccidiose-vacciner
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
HUP0200832A2 (hu) Babesia canis oltóanyag
ATE374622T1 (de) Genetische impstoffe mit adjuvans
WO2004024769A3 (en) Ostertagia vaccine
ATE450546T1 (de) Impfstoffe mit ornithobakterium rhinotracheale- untereinheit
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis